New PIC/S Q&A Document regarding Distribution Activities for APIs
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The range of documents (Aide Memoires and Guidance Documents) available for PIC/S inspectors has been extended to the category of Questions & Answers documents.
The first Q&A document published is intended to support inspectors during API inspections regarding distribution activities and repackaging.
Some answers refer to
Part II of the PIC/S Guide. It seems to be useful against the background of the revised Pharma Directive 2001/83/EC through which inspections in the logistics chain will become more and more important.Here are some of the topics dealt with in the 13 questions and answers:
- Should financial records in addition to GMP documents be examined during inspections?
- How can the finished product manufacturer be sure about the integrity of the whole API supply chain?
- Which kind of information is requested about transport conditions of APIs and is a transport validation needed?
- On which aspects should inspectors focus on during inspections of brokers/traders?
- What are repackaging and relabelling activities, particularly since PIC/S GMP Guide Part II gives no definition of them?
- Should stability studies be conducted on repackaged APIs?
For details please see the
new Q&A document available on the PIC/S website.Author
Dr Robert Eicher
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


